Multiple Sclerosis (MS) Drugs

| Avonex | Betaseron | Betaferon | Copaxone | Rebif |

 

Rebif (interferon beta-1a)

What is Rebif ?

Rebif is a drug used in the treatment of multiple sclerosis. It is from a class of drugs known as interferons.

Interferon beta-1a is a recombinant DNA produced synthetic of naturally occurring proteins.

Interferons are cytokines. Three major classes of interferon have been identified - interferon alpha, interferon beta and interferon gamma. Interferon alpha and beta form the Type I class of interferons and Interferon gamma is a Type II interferon.

Interferons are species specific. The effects and results of interferon therapy and animal experimentation is difficult to apply across the human-animal species barriers since the effects they have within any given species are different.

The specific interferon-induced proteins and mechanisms by which interferon beta-1a exerts its effects in multiple sclerosis (MS) have not been fully defined.

Rebif is administered by subcutaneous injection (injection under the skin) three times weekly.

 

 

 

 

 

Multiple Sclerosis

The average age of diagnosis of Multiple Sclerosis is 37 years of age.

MS Drugs

It should be noted that the multiple sclerosis drugs currently in use to treat MS are immunomodulatory. This means the approved drugs used specifically in the treatment of multiple sclerosis have a direct effect on the workings and efficiency of the normal immune system... Read More